This site uses cookies. By using this site you agree to receiving cookies. View Policy.
Successfully funded
/https://files-crowdcube-com.s3.amazonaws.com/files/pitch_pics/original/201709/4a054e2510e1b5580a09b92c18423ac2.jpg)
Molecular Warehouse, backed by Oxford Technology, has a disruptive, patented biosensor technology designed to enable people to monitor their health using their smartphones. Since their last raise, has had patents granted, and signed a partnership with an international Pharma company.
- Partnership signed with international pharmaceutical company
- Experienced team and backing from specialised VCs
- This pitch is private and limited to existing investors
- The information below has not been verified by Crowdcube
This is a private pitch open to the company's existing investors only. It is therefore not necessary for Crowdcube to approve this pitch as a financial promotion. As Crowdcube has not carried out any due diligence on this pitch, the Due Diligence Charter does not apply. Investors should carry out their own due diligence and take professional advice where necessary.
Idea
Our vision is to create a world where most diseases are prevented, by giving people the ability to monitor and manage their health using their smartphones, anywhere, anytime.
We have used synthetic biology to re-engineer the most successful personal diagnostic system, the glucose monitor, which millions of diabetic patients use every day, to be able to detect many other diseases.
Initial applications currently in development target chronic kidney disease, which affects almost 10% of the population worldwide, hemophilia, chronic stress, vitamin D levels, and acute pancreatitis.
Our innovative system is protected by six international patents, and we have unique proprietary assets in synthetic biology, electronics, software algorithms, and data encryption and patient privacy.
KEY PROGRESS SINCE LAST CROWDCUBE ROUND:
> Signed a partnership with an international Pharma company, which included a £215,000 upfront fee and contains over £10m in technical- and sales-based milestone payments
> Developed fully working pre-manufacturing prototype of our Bluetooth-enabled test reader
> Moved to automated manufacturing for our test strips
> Recruited 6 new employees and moved to purpose-built laboratories at the Surrey Research Park
> Filed one new patent, and had two patents granted in USA and one granted in Europe
> Successfully passed ISO13485 & ISO9001 level 1 audit
THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE BY THE COMPANY RAISING FINANCE AS IDENTIFIED ABOVE (THE "COMPANY") IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY AND SUBJECT TO THESE TERMS AND CONDITIONS. CROWDCUBE CAPITAL LTD IS AUTHORISED BY THE FCA AND CARRIES OUT DUE DILIGENCE ON EACH COMPANY THAT LISTS ON CROWDCUBE AS SET OUT HERE.
This investment opportunity is not an offer to the public and is only available to registered members of Crowdcube.com who have qualified and categorised themselves as able to invest. The investment opportunity is not directed at persons located in the United States, Canada or Japan. Any person resident outside the United Kingdom who wishes to view these materials must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict access.
In particular, unless otherwise determined by the Company and permitted by applicable law and regulation, it is not intended, subject to certain exceptions, that any offering of the securities mentioned in such materials (the "Securities") by the Company would be made, or any documentation be sent in or into, the United States, Canada or Japan. There will be no public offering of the Securities in the United States.
In order to access the pitch you must first become a qualifying member of Crowdcube on the basis of your status as either (i) self-certified ‘high net worth investor’, (ii) certified ‘sophisticated investor’, (iii) self-certified as a ‘sophisticated investor’ or (iv) certified as a ‘restricted investor’, in each case in accordance with the FCA’s Conduct of Business Sourcebook Chapter 4.7. Potential investors are encouraged to "cross examine" the Company by interactive due diligence and use of the available online forums to bring the "wisdom of the crowd" to bear. Accessing the pitch also means you agree to Crowdcube’s most recent website terms and conditions and investor terms and conditions, which include Crowdcube's limitation of liability.
If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage. Crowdcube’s or the Issuer’s press announcements and this information page do not constitute an offer to sell securities of the Company. Further, it does not constitute a recommendation by the Company, Crowdcube or any other party to sell or buy securities in the Company.
By registering or logging into Crowdcube.com to view the investment opportunity, you certify that you are legally entitled to view the investment opportunities, are an authorised investor and you agree to all applicable terms and conditions on this website, including this disclaimer.
To see the rest of the Molecular Warehouse pitch, join now.
It’s free, quick and easy.
Already registered? Log in
To see the rest of the Molecular Warehouse pitch, join now.
It’s free, quick and easy.
/https://files-crowdcube-com.s3.amazonaws.com/files/pitch_pics/original/201709/4a054e2510e1b5580a09b92c18423ac2.jpg)
